Limited Competition: Resources and Workforce Development for the Regional Biocontainment Laboratories
National Institutes of Health · Department of Health and Human Services · RFA-AI-28-013
In plain English
National Institutes of Health (Department of Health and Human Services) has announced this as a forecast: an opportunity it expects to post. It is not open for applications yet. Estimated posting date: Jul 2, 2027. Estimated application due date: Sep 30, 2027.
The agency expects to make 12 awards and estimated total program funding is $36,000,000.
Eligible applicant types include colleges & universities.
The listing says cost sharing or matching is not required.
Built only from the fields in the Grants.gov listing. Always confirm on the official listing.
Key facts
| Status | Forecasted: not open yet |
|---|---|
| Estimated posting date | Jul 2, 2027 |
| Estimated application due date | Sep 30, 2027 |
| Estimated award date | Aug 1, 2028 |
| Estimated project start | Aug 1, 2028 |
| Fiscal year | 2028 |
| Forecast posted | Jun 24, 2026 |
| Opportunity number | RFA-AI-28-013 |
| Agency | National Institutes of Health (Department of Health and Human Services) |
| Funding instrument | Cooperative agreement |
| Category | Health |
| Opportunity category | Discretionary |
| Award ceiling (max per award) | Not stated |
| Award floor (min per award) | Not stated |
| Estimated total program funding | $36,000,000 |
| Expected number of awards | 12 |
| Cost sharing or matching required | No |
| Assistance listing (CFDA/ALN) | 93.855 – Allergy and Infectious Diseases Research |
| Last updated on Grants.gov | Jun 24, 2026 |
Who can apply
Browse similar: Colleges & universities
- Public and state-controlled institutions of higher education
- Private institutions of higher education
Additional eligibility information (excerpt from the listing):
Eligible ApplicantsUniversity of Alabama at BirminghamTulane UniversityUniversity of TennesseeGeorge Mason UniversityDuke UniversityRutgers UniversityTufts UniversityUniversity of PittsburghUniversity of ChicagoUniversity of MissouriUniversity of LouisvilleColorado State University
Description
Excerpt from the official forecast on Grants.gov (shortened; read the full text on the official listing):
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by providing critical resources, staff and facilities support for the Regional Biocontainment Laboratories (RBLs). The RBLs provide biosafety level 2 and 3 (BSL-2/3) biocontainment facilities for research on infectious diseases. They play a critical role in public health emergency response by facilitating key activities related to infectious disease outbreaks and biosafety/biosecurity concerns. Congress has denoted the RBLs a NIAID research priority. This program will provide multi-year funding for facility maintenance, operations and biocontainment-specific training for personnel to maintain a capable BSL-3 level workforce in the United States. This is a Forecast for a Limited Competition that will invite application(s) from eligible organization(s) to apply. …
More Department of Health and Human Services grants closing soon
All →- 2days leftNCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)NonprofitsSmall businessesFor-profit companies+6 moreHealth
- 2days leftNCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)NonprofitsSmall businessesFor-profit companies+6 moreHealth
- 2days leftNCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)NonprofitsSmall businessesFor-profit companies+6 moreHealth
- 2days leftNIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)NonprofitsSmall businessesFor-profit companies+6 moreEducation
More health grants closing soon
All →- 5days leftEthical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)NonprofitsSmall businessesFor-profit companies+6 moreEducation
- 6days leftSingle Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)NonprofitsSmall businessesFor-profit companies+6 moreHealth
- 6days leftPrevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)NonprofitsSmall businessesFor-profit companies+6 moreHealth
- 6days leftFeasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)NonprofitsSmall businessesFor-profit companies+6 moreHealth